This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...
Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...
Obeid emphasized that risk assessment is a critical part of ongoing cancer care. It helps patients and their families understand the cancer’s causes, informs treatment options and supports strategies ...
The transition to a survivorship program evokes complex emotions, including excitement, hesitation, and survivor's guilt, as ...
Despite its popularity, biotin lacks strong evidence for hair regrowth, and safer alternatives like minoxidil are recommended ...
The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
Researchers have revealed how patients with metastatic breast cancer develop resistance to Enhertu treatment.
Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of medicine ...
Cleveland Clinic researchers have found that nearly two-thirds of patients with HER2-positive metastatic breast cancer did ...
Caregivers can neglect routine medical care, such as attending doctor’s appointments, getting screenings, taking medications, ...
Dr. Tracy Proverbs-Singh explains that caregivers may neglect screenings, medications, rest, and hydration, risking their own health. Dr. Tracy Proverb-Sign explains how a multidisciplinary team helps ...
Breast cancer survivors face increased skin cancer risk, necessitating regular dermatological check-ups and self-examinations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results